地奥司明在氯胺酮诱导的小鼠精神分裂症模型中的抗精神病作用:氧化应激和胆碱能传导的参与

IF 2 Q3 NEUROSCIENCES
Benneth Ben-Azu , Olusegun G. Adebayo , Aliance Romain Fokoua , Benjamin Oritsemuelebi , Emmanuel O. Chidebe , Chukwuebuka B. Nwogueze , Lenatababari Kumanwee , God'swill E. Uyere , Micheal T. Emuakpeje
{"title":"地奥司明在氯胺酮诱导的小鼠精神分裂症模型中的抗精神病作用:氧化应激和胆碱能传导的参与","authors":"Benneth Ben-Azu ,&nbsp;Olusegun G. Adebayo ,&nbsp;Aliance Romain Fokoua ,&nbsp;Benjamin Oritsemuelebi ,&nbsp;Emmanuel O. Chidebe ,&nbsp;Chukwuebuka B. Nwogueze ,&nbsp;Lenatababari Kumanwee ,&nbsp;God'swill E. Uyere ,&nbsp;Micheal T. Emuakpeje","doi":"10.1016/j.ibneur.2023.12.008","DOIUrl":null,"url":null,"abstract":"<div><p>A decrease in the levels of antioxidant arsenals exacerbate generation of reactive oxygen/nitrogen species, leading to neurochemical dysfunction, with significant impact on the pathogenesis of psychotic disorders such as schizophrenia. This study examined the preventive and reversal effects of diosgenin, a phyto-steroidal saponin with antioxidant functions in mice treated with ketamine which closely replicates schizophrenia-like symptoms in human and laboratory animals. In the preventive phase, adult mice cohorts were clustered into 5 groups (<em>n</em> = 9). Groups 1 and 2 received saline (10 mL/kg, <em>i.p.),</em> groups 3 and 4 were pretreated with diosgenin (25 and 50 mg/kg), and group 5 received risperidone (0.5 mg/kg) orally for 14 days. Mice in groups 2–5 additionally received a daily dose of ketamine (20 mg/kg, <em>i.p.</em>) or saline (10 mL/kg/day, <em>i.p.</em>). In the reversal phase, mice received intraperitoneal injection of ketamine or saline for 14 consecutive days prior to diosgenin (25 and 50 mg/kg/<em>p.o.</em>/day) and risperidone (0.5 mg/kg/<em>p.o</em>./day) treatment from days 8–14. Mice were assessed for behavioral changes. Oxidative, nitrergic markers, and cholinergic (acetylcholinesterase activity) transmission were examined in the striatum, prefrontal-cortex and hippocampus. Diosgenin prevented and reversed hyperlocomotion, cognitive and social deficits in mice treated with ketamine relative to ketamine groups. The increased acetylcholinesterase, malondialdehyde and nitrite levels produced by ketamine were reduced by diosgenin in the striatum, prefrontal-cortex and hippocampus, but did not reverse striatal nitrite level. Diosgenin increased glutathione, and catalase levels, except for hippocampal catalase activity when compared with ketamine controls. Conclusively, these biochemical changes might be related to the behavioral deficits in ketamine-treated mice, which were prevented and reversed by diosgenin.</p></div>","PeriodicalId":13195,"journal":{"name":"IBRO Neuroscience Reports","volume":"16 ","pages":"Pages 86-97"},"PeriodicalIF":2.0000,"publicationDate":"2024-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667242123022960/pdfft?md5=ac5ff5382981927d22ab5b98683fe104&pid=1-s2.0-S2667242123022960-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission\",\"authors\":\"Benneth Ben-Azu ,&nbsp;Olusegun G. Adebayo ,&nbsp;Aliance Romain Fokoua ,&nbsp;Benjamin Oritsemuelebi ,&nbsp;Emmanuel O. Chidebe ,&nbsp;Chukwuebuka B. Nwogueze ,&nbsp;Lenatababari Kumanwee ,&nbsp;God'swill E. Uyere ,&nbsp;Micheal T. Emuakpeje\",\"doi\":\"10.1016/j.ibneur.2023.12.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A decrease in the levels of antioxidant arsenals exacerbate generation of reactive oxygen/nitrogen species, leading to neurochemical dysfunction, with significant impact on the pathogenesis of psychotic disorders such as schizophrenia. This study examined the preventive and reversal effects of diosgenin, a phyto-steroidal saponin with antioxidant functions in mice treated with ketamine which closely replicates schizophrenia-like symptoms in human and laboratory animals. In the preventive phase, adult mice cohorts were clustered into 5 groups (<em>n</em> = 9). Groups 1 and 2 received saline (10 mL/kg, <em>i.p.),</em> groups 3 and 4 were pretreated with diosgenin (25 and 50 mg/kg), and group 5 received risperidone (0.5 mg/kg) orally for 14 days. Mice in groups 2–5 additionally received a daily dose of ketamine (20 mg/kg, <em>i.p.</em>) or saline (10 mL/kg/day, <em>i.p.</em>). In the reversal phase, mice received intraperitoneal injection of ketamine or saline for 14 consecutive days prior to diosgenin (25 and 50 mg/kg/<em>p.o.</em>/day) and risperidone (0.5 mg/kg/<em>p.o</em>./day) treatment from days 8–14. Mice were assessed for behavioral changes. Oxidative, nitrergic markers, and cholinergic (acetylcholinesterase activity) transmission were examined in the striatum, prefrontal-cortex and hippocampus. Diosgenin prevented and reversed hyperlocomotion, cognitive and social deficits in mice treated with ketamine relative to ketamine groups. The increased acetylcholinesterase, malondialdehyde and nitrite levels produced by ketamine were reduced by diosgenin in the striatum, prefrontal-cortex and hippocampus, but did not reverse striatal nitrite level. Diosgenin increased glutathione, and catalase levels, except for hippocampal catalase activity when compared with ketamine controls. Conclusively, these biochemical changes might be related to the behavioral deficits in ketamine-treated mice, which were prevented and reversed by diosgenin.</p></div>\",\"PeriodicalId\":13195,\"journal\":{\"name\":\"IBRO Neuroscience Reports\",\"volume\":\"16 \",\"pages\":\"Pages 86-97\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-01-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2667242123022960/pdfft?md5=ac5ff5382981927d22ab5b98683fe104&pid=1-s2.0-S2667242123022960-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IBRO Neuroscience Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667242123022960\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IBRO Neuroscience Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667242123022960","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

抗氧化剂水平的降低会加剧活性氧/氮物种的生成,导致神经化学功能失调,对精神分裂症等精神疾病的发病机制产生重大影响。这项研究考察了具有抗氧化功能的植物甾体皂苷 diosgenin 对氯胺酮治疗小鼠的预防和逆转作用。在预防阶段,成年小鼠被分为 5 组(n = 9)。第 1 组和第 2 组接受生理盐水(10 毫升/千克,静脉注射),第 3 组和第 4 组接受地奥司宁(25 毫克/千克和 50 毫克/千克)预处理,第 5 组口服利培酮(0.5 毫克/千克)14 天。此外,2-5 组的小鼠每天接受一定剂量的氯胺酮(20 毫克/千克,静脉注射)或生理盐水(10 毫升/千克/天,静脉注射)。在逆转阶段,小鼠连续14天腹腔注射氯胺酮或生理盐水,然后在第8-14天接受地奥司宁(25和50毫克/千克/磅/天)和利培酮(0.5毫克/千克/磅/天)治疗。对小鼠的行为变化进行评估。对纹状体、前额叶皮质和海马的氧化、硝酸标记物和胆碱能(乙酰胆碱酯酶活性)传递进行了检测。与氯胺酮组相比,薯蓣皂苷能防止和逆转氯胺酮组小鼠的过度运动、认知和社交障碍。在纹状体、前额叶皮质和海马中,地奥司明能降低氯胺酮导致的乙酰胆碱酯酶、丙二醛和亚硝酸盐水平的升高,但不能逆转纹状体的亚硝酸盐水平。与氯胺酮对照组相比,薯蓣皂苷提高了谷胱甘肽和过氧化氢酶水平,但海马过氧化氢酶活性除外。最后,这些生化变化可能与氯胺酮治疗小鼠的行为缺陷有关,而地奥司明能防止和逆转这些行为缺陷。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission

A decrease in the levels of antioxidant arsenals exacerbate generation of reactive oxygen/nitrogen species, leading to neurochemical dysfunction, with significant impact on the pathogenesis of psychotic disorders such as schizophrenia. This study examined the preventive and reversal effects of diosgenin, a phyto-steroidal saponin with antioxidant functions in mice treated with ketamine which closely replicates schizophrenia-like symptoms in human and laboratory animals. In the preventive phase, adult mice cohorts were clustered into 5 groups (n = 9). Groups 1 and 2 received saline (10 mL/kg, i.p.), groups 3 and 4 were pretreated with diosgenin (25 and 50 mg/kg), and group 5 received risperidone (0.5 mg/kg) orally for 14 days. Mice in groups 2–5 additionally received a daily dose of ketamine (20 mg/kg, i.p.) or saline (10 mL/kg/day, i.p.). In the reversal phase, mice received intraperitoneal injection of ketamine or saline for 14 consecutive days prior to diosgenin (25 and 50 mg/kg/p.o./day) and risperidone (0.5 mg/kg/p.o./day) treatment from days 8–14. Mice were assessed for behavioral changes. Oxidative, nitrergic markers, and cholinergic (acetylcholinesterase activity) transmission were examined in the striatum, prefrontal-cortex and hippocampus. Diosgenin prevented and reversed hyperlocomotion, cognitive and social deficits in mice treated with ketamine relative to ketamine groups. The increased acetylcholinesterase, malondialdehyde and nitrite levels produced by ketamine were reduced by diosgenin in the striatum, prefrontal-cortex and hippocampus, but did not reverse striatal nitrite level. Diosgenin increased glutathione, and catalase levels, except for hippocampal catalase activity when compared with ketamine controls. Conclusively, these biochemical changes might be related to the behavioral deficits in ketamine-treated mice, which were prevented and reversed by diosgenin.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
IBRO Neuroscience Reports
IBRO Neuroscience Reports Neuroscience-Neuroscience (all)
CiteScore
2.80
自引率
0.00%
发文量
99
审稿时长
14 weeks
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信